A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
A modified procedure for ilio-inguinal regional lymph node dissection (I-I RLND) involving 2 small skin incisions was evaluated with the aim of assessing surgical and oncological noninferiority compared with the traditional single, longitudinal incision I-I RLND.
Materials and Methods
A total of 20 melanoma patients with positive groin lymph nodes who had traditional I-I RLND were compared with 20 patients who had a minimal access I-I RLND using 2 small surgical access incisions of 3–6 cm in length—one sited below and one above the inguinal ligament. Clinical, staging features, number of lymph nodes retrieved, length of hospital stay, time drains remained in situ, morbidity (wound infections, dehiscence, hematoma, seroma, and lymphedema), and disease free survival were compared.
Patients in the groups were comparable with the exception that the minimal access I-I RLND group had a higher rate of AJCC stage N3 disease (60% vs 20%; P = .03) and more cases with extranodal spread (45% vs 15%; P = .041). After a median follow-up of 5 months (range 1–8) for the minimal access group and median 13 months (range 1–30) for the standard group there were no differences in disease-free survival (P = .13). Retrieved lymph node counts were similar (P = .34) including for the inguinal and pelvic components of the operations separately. No significant differences in wound complications or rates of early lymphedema were observed.
At early follow-up, minimal access I-I RLND is feasible and noninferior to single longitudinal incision I-I RLND in regard to surgical morbidity and oncological outcome. Further evaluation is progressing.
- Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, et al. Melanoma. J Natl Compr Cancer Netw. 2009;7:250–75.
- Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand, C.C. Australia, A.C. Network, S.A.N.Z.G. Group. Wellington, 2008.
- Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy. Available from: http://clinicaltrial.gov/ct2/show/NCT00389571?term=MSLT&rank=8, July 6, 2010.
- MINITUB Study. Available from: http://www.melanomagroup.eu/content/view/101/117/, October 9, 2010.
- Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793–6. CrossRef
- Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17. CrossRef
- Pasquali S, Mocellin S, Campana LG, Bonandini E, Montesco MC, Tregnaghi A, et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer. 2010;116:1201–9. CrossRef
- Galliot-Repkat C, Cailliod R, Trost O, Sanino A, Collet E, Lambert D, et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol. 2006;32:790–4. CrossRef
- Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to AJCC N stage in patients with melanoma, even if the quality of surgery is standardized. Ann Surg. 2010; [Epub ahead of print].
- Spillane AJ, Winstanley J, Thompson JF. Lymph node ratio in melanoma: a marker of variation in surgical quality? Cancer. 2009;115:2384–7. CrossRef
- Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115:2505–13. CrossRef
- Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15:310–5. CrossRef
- Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst. 2010;102:493–501. CrossRef
- Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493–8. CrossRef
- van der Ploeg IM, Kroon BB, Valdes Olmos RA, Nieweg OE. Evaluation of lymphatic drainage patterns to the groin and implications for the extent of groin dissection in melanoma patients. Ann Surg Oncol. 2009;16:2994–9. CrossRef
- Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14:2867–75. CrossRef
- Chang SB, Askew RL, Xing Y, Weaver S, Gershenwald JE, Lee JE, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17:2764–72. CrossRef
- Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687–93. CrossRef
- Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248:286–93. CrossRef
- Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728–35. CrossRef
- de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:2840–7. CrossRef
- de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32:785–9. CrossRef
- Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozillo N. The Impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17:3324–9. CrossRef
- Moseley A, Piller N, Carati C. Combined opto-electronic perometry and bioimpedance to measure objectively the effectiveness of a new treatment intervention for chronic secondary leg lymphedema. Lymphology. 2002;35:136–43.
- Jacobs LK, Balch C, Coit DG. Inguinofemoral, iliac/obturator, and popliteal lymphadenectomy in patients with melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma, St. Louis, MO: Quality Medical Publishing; 2009.
- Spratt J. Groin dissection. J Surg Oncol. 2000;73:243–62. CrossRef
- Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg. 251:632–9.
- Spratt JS. An update on incision for ilioinguinal lymph node dissection. Am J Surg. 1992;164:163–5; discussion 166. CrossRef
- Rapaport D, Stadelmann WK, Reintgen D. Inguinal lymphadenectomy. In Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma. St. Louis, MO: Quality Medical Publishing; 2009. p. 269–80.
- Spillane AJ, Cheung BL, Stretch JR, Scolyer RA, Shannon KF, Quinn MJ, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249:473–80. CrossRef
- Ali-Khan AS, Crundwell M, Stone C. Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma. J Plast Reconstr Aesthet Surg. 2009;62:1063–7. CrossRef
- Jones WO, Cable RL, Gilling PJ. Laparoscopic pelvic lymphadenectomy for malignant melanoma. Aust N Z J Surg. 1995;65:765–7. CrossRef
- Picciotto F, Volpi E, Zaccagna A, Siatis D. Transperitoneal laparoscopical iliac lymphadenectomy for treatment of malignant melanoma. Surg Endosc. 2003;17:1536–40. CrossRef
- Schneider C, Brodersen JP, Scheuerlein H, Tamme C, Lippert H, Kockerling F. Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg. 2003;388:42–7.
- Trias M, Targarona EM, Piulachs J, Balagué C, Bombuy E, Espert JJ, et al. Extraperitoneal laparoscopically assisted ilioinguinal lymphadenectomy for treatment of malignant melanoma. Arch Surg. 1998;133:272–4; discussion 275. CrossRef
- Delman KA, Kooby DA, Ogan K, Hsiao W, Master V. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010;17:731–7. CrossRef
- Delman KA, Kooby DA, Rizzo K, Organ K, Maithel SK, Master V. Growing experience with videoscopic inguinal lymphadenectomy (VIL): moving to better outcomes. Ann Surg Oncol. 2010;17:S15.
- Hughes TM, A’Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892–901. CrossRef
- Sommariva A, Pasquali S, Rossi CR. Lymphadenectomy for melanoma: towards a videoscopic approach. Ann Surg Oncol. 2010 [Epub ahead of print].
- A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions
Annals of Surgical Oncology
Volume 18, Issue 4 , pp 970-976
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Sydney Medical School, The University of Sydney, Sydney, Australia
- 2. Melanoma Institute Australia, Sydney, Australia
- 3. The Mater Hospital, North Sydney, Australia
- 4. Royal Prince Alfred Hospital, Camperdown, Australia
- 5. Royal North Shore Hospital, St. Leonards, Australia
- 6. Breast and Surgical Oncology at the Poche Centre, 40 Rocklands Road, North Sydney, Australia
- 7. University of Padova, Padova, Italy
- 8. Melanoma and Sarcomas Unit, Venetian Oncological Institute, Padova, Italy